ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up

Cardiovascular Research, 2022 - academic.oup.com
Aims Since its emergence in early 2020, the novel severe acute respiratory syndrome
coronavirus 2 causing coronavirus disease 2019 (COVID-19) has reached pandemic levels …

Impact of COVID-19 on cardiovascular disease

I Vosko, A Zirlik, H Bugger - Viruses, 2023 - mdpi.com
Coronavirus disease 2019 (COVID-19) is a viral infection with the novel severe acute
respiratory distress syndrome corona virus 2 (SARS-CoV-2). Until now, more than 670 …

Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study

CT Rentsch, JA Beckman, L Tomlinson, WF Gellad… - Bmj, 2021 - bmj.com
Objective To evaluate whether early initiation of prophylactic anticoagulation compared with
no anticoagulation was associated with decreased risk of death among patients admitted to …

New-onset atrial fibrillation in patients hospitalized with COVID-19: results from the American Heart Association COVID-19 cardiovascular registry

AG Rosenblatt, CR Ayers, A Rao… - Circulation …, 2022 - Am Heart Assoc
Background: New-onset atrial fibrillation (AF) in patients hospitalized with COVID-19 has
been reported and associated with poor clinical outcomes. We aimed to understand the …

[HTML][HTML] Factors associated with myocardial SARS-CoV-2 infection, myocarditis, and cardiac inflammation in patients with COVID-19

M Bearse, YP Hung, AJ Krauson, L Bonanno, B Boyraz… - Modern Pathology, 2021 - Elsevier
COVID-19 has been associated with cardiac injury and dysfunction. While both myocardial
inflammatory cell infiltration and myocarditis with myocyte injury have been reported in …

Prevalence and impact of atrial fibrillation in hospitalized patients with COVID-19: a systematic review and meta-analysis

GF Romiti, B Corica, GYH Lip, M Proietti - Journal of clinical medicine, 2021 - mdpi.com
Background: In patients with COVID-19, cardiovascular complications are common and
associated with poor prognosis. Among these, an association between atrial fibrillation (AF) …

European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology …

Task Force for the management of COVID … - Cardiovascular …, 2022 - academic.oup.com
Aims Since its emergence in early 2020, the novel severe acute respiratory syndrome
coronavirus 2 causing coronavirus disease 2019 (COVID-19) has reached pandemic levels …

European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology …

European Heart Journal, 2022 - academic.oup.com
Aims Since its emergence in early 2020, the novel severe acute respiratory syndrome
coronavirus 2 causing coronavirus disease 2019 (COVID-19) has reached pandemic levels …

Prevalence of atrial fibrillation and associated mortality among hospitalized patients with COVID-19: a systematic review and meta-analysis

Z Li, W Shao, J Zhang, J Ma, S Huang, P Yu… - Frontiers in …, 2021 - frontiersin.org
Background: Epidemiological studies have shown that atrial fibrillation (AF) is a potential
cardiovascular complication of coronavirus disease 2019 (COVID-19). We aimed to perform …

Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study

S Paris, RM Inciardi, CM Lombardi, D Tomasoni… - EP …, 2021 - academic.oup.com
Aims To assess the clinical relevance of a history of atrial fibrillation (AF) in hospitalized
patients with coronavirus disease 2019 (COVID-19). Methods and results We enrolled 696 …